Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy

被引:64
|
作者
Senra, Tiago [1 ,2 ]
Ianni, Barbara M. [1 ]
Costa, Ana C. P. [1 ]
Mady, Charles [1 ]
Martinelli-Filho, Martino [1 ]
Kalil-Filho, Roberto [1 ]
Rochitte, Carlos E. [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Ave Dr Eneas de Carvalho Aguiar 44, BR-05403000 Sao Paulo, SP, Brazil
[2] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
cardiac magnetic resonance; Chagas cardiomyopathy; myocardial fibrosis; prognosis; delayed enhancement; MORTALITY; DISEASE; QUANTIFICATION; PREDICTORS; DEATH;
D O I
10.1016/j.jacc.2018.08.2195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Myocardial fibrosis (MF) according to cardiac magnetic resonance (CMR) is a frequent finding in Chagas cardiomyopathy and has been associated with risk factors of poor outcome. OBJECTIVES The goal of this study was to determine the prognostic value of MF in predicting combined hard events or all-cause mortality. METHODS Patients with Chagas cardiomyopathy who had a previous CMR evaluation were included, and clinical follow-up was retrospectively obtained. The primary outcome was a combination of all-cause mortality, heart transplantation, antitachycardia pacing or appropriate shock from an implantable cardioverter-defibrillator, and aborted sudden cardiac death; the secondary outcome was all-cause mortality. RESULTS A total of 130 patients were included; mean age was 53.6 +/- 11.5 years, and 53.9% were female. The majority of patients reported no symptoms of heart failure or arrhythmia, but electrocardiographic and echocardiographic abnormalities were common. On CMR, left ventricular dilatation and dysfunction were frequent, and MF was found in 76.1%, with a mean mass of 15.2 +/- 16.5 g. Over a median follow-up of 5.05 years, 58 (44.6%) patients reached the combined endpoint, and 45 (34.6%) patients died. MF was associated with the primary outcome as a continuous variable (adjusted hazard ratio: 1.031; 95% CI: 1.013 to 1.049; p = 0.001) and as a categorical variable (MF >= 12.3 g) (adjusted hazard ratio: 2.107; 95% CI: 1.111 to 3.994; p = 0.022), independently from the Rassi risk score. MF expressed as a continuous variable was also associated with all-cause mortality (adjusted hazard ratio: 1.028; 95% CI: 1.005 to 1.051; p = 0.017) independently from the Rassi risk score. CONCLUSIONS MF is an independent predictor of adverse outcome in Chagas cardiomyopathy. Our data may support the use of CMR in better risk-stratifying this population and possibly guiding therapy. (c) 2018 by the American College of Cardiology Foundation.
引用
收藏
页码:2577 / 2587
页数:11
相关论文
共 50 条
  • [21] Long-term outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy
    Liu, F.
    Zhou, Y. J.
    Ge, H. L.
    EUROPEAN HEART JOURNAL, 2018, 39 : 648 - 648
  • [22] THE LONG-TERM PROGNOSTIC VALUE OF THE FRAMINGHAM RISK SCORING IN PATIENTS WITH MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES
    Zhang, Hao
    Fang, Yanwen
    Huang, Sizhuang
    Zhong, Lingzhi
    Yu, Mengyue
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12) : 1872 - 1872
  • [23] Long-term prognostic value of quantitative myocardial perfusion in patients with chest pain and normal coronary arteries
    Andrea G. Monroy-Gonzalez
    R. A. Tio
    J. C. de Groot
    H. H. Boersma
    N. H. Prakken
    M. J. L. De Jongste
    E. Alexanderson-Rosas
    R. H. J. A. Slart
    Journal of Nuclear Cardiology, 2019, 26 : 1844 - 1852
  • [24] Long-term prognostic value of quantitative myocardial perfusion in patients with chest pain and normal coronary arteries
    Monroy-Gonzalez, Andrea G.
    Tio, R. A.
    de Groot, J. C.
    Boersma, H. H.
    Prakken, N. H.
    De Jongste, M. J. L.
    Alexanderson-Rosas, E.
    Slart, R. H. J. A.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2019, 26 (06) : 1844 - 1852
  • [25] Prognostic value of peak exercise systolic blood pressure on the long-term survival of myocardial infarction patients
    Dorn, J
    Naughton, J
    Schisterman, E
    Trevisan, M
    CIRCULATION, 1998, 97 (08) : 826 - 826
  • [26] MYOCARDITIS AND MYOCARDIAL FIBROSIS IN A LONG-TERM EXPERIMENT
    SCHENK, KE
    GROSS, UM
    ZEITSCHRIFT FUR KARDIOLOGIE, 1974, 63 (09): : 842 - 849
  • [27] Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?
    Nakazone, Marcelo Arruda
    Otaviano, Ana Paula
    Machado, Mauricio Nassau
    Bestetti, Reinaldo Bulgarelli
    CARDIOLOGY JOURNAL, 2022, 29 (01) : 44 - 52
  • [28] Left Atrial Volume Provides Independent Prognostic Value in Patients With Chagas Cardiomyopathy
    Nunes, Maria Carmo P.
    Barbosa, Marcia M.
    Ribeiro, Antonio Luiz P.
    Colosimo, Enrico A.
    Rocha, Manoel O. C.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (01) : 82 - 88
  • [29] Prevalence and Prognostic Value of Ventricular Dyssynchrony in Chagas' Cardiomyopathy
    Pinheiro Duarte, Jussara de Oliveira
    de Magalhaes, Luiz Pereira
    Santana, Oto Oliveira
    da Silva, Leandro Barros
    Simoes, Monique
    de Azevedo, Darluce Oliveira
    Barbosa Junior, Octavio Alencar
    Fagundes, Alexsandro Alves
    Farias Borges dos Reis, Francisco Jose
    Lemos Correia, Luis Claudio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 96 (04) : 300 - 305
  • [30] Galectin 3 and chagas cardiomyopathy: relationship of this myocardial fibrosis marker with myocardial deformation measured by speckle tracking in patients with chagas disease
    Eduardo Echeverria, L. E. Luis
    Calvo-Betancourt, L. S.
    Roa-Diaz, Z. M.
    Rojas-Sanchez, L. Z.
    Campo-Torrenegra, R. I.
    Villamizar, M. C.
    Redondo-Gelvez, A. M.
    Torres-Bustamante, A. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 100 - 100